vs
Side-by-side financial comparison of Brown & Brown (BRO) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
Brown & Brown is the larger business by last-quarter revenue ($1.6B vs $1.5B, roughly 1.1× BeOne Medicines Ltd.). Brown & Brown runs the higher net margin — 16.5% vs 4.4%, a 12.1% gap on every dollar of revenue. On growth, Brown & Brown posted the faster year-over-year revenue change (35.8% vs 32.8%). Brown & Brown produced more free cash flow last quarter ($424.0M vs $379.8M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 13.0%).
Brown & Brown, Inc. is an American insurance brokerage firm headquartered in Daytona Beach, Florida. It is one of the largest independent insurance intermediaries in the United States, providing risk management solutions, insurance products, and services to businesses, governmental institutions, professional organizations, trade associations, and individuals.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
BRO vs ONC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.6B | $1.5B |
| Net Profit | $265.0M | $66.5M |
| Gross Margin | — | 90.5% |
| Operating Margin | — | 12.4% |
| Net Margin | 16.5% | 4.4% |
| Revenue YoY | 35.8% | 32.8% |
| Net Profit YoY | 26.8% | 143.8% |
| EPS (diluted) | $0.55 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.6B | $1.5B | ||
| Q3 25 | $1.6B | $1.4B | ||
| Q2 25 | $1.3B | $1.3B | ||
| Q1 25 | $1.4B | $1.1B | ||
| Q4 24 | $1.2B | $1.1B | ||
| Q3 24 | $1.2B | $1.0B | ||
| Q2 24 | $1.2B | $929.2M | ||
| Q1 24 | $1.3B | $751.7M |
| Q4 25 | $265.0M | $66.5M | ||
| Q3 25 | $227.0M | $124.8M | ||
| Q2 25 | $231.0M | $94.3M | ||
| Q1 25 | $331.0M | $1.3M | ||
| Q4 24 | $209.0M | $-151.9M | ||
| Q3 24 | $234.0M | $-121.3M | ||
| Q2 24 | $257.0M | $-120.4M | ||
| Q1 24 | $293.0M | $-251.2M |
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 86.1% | ||
| Q2 25 | — | 87.5% | ||
| Q1 25 | — | 85.2% | ||
| Q4 24 | — | 85.8% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | — | 85.1% | ||
| Q1 24 | — | 83.4% |
| Q4 25 | — | 12.4% | ||
| Q3 25 | — | 11.5% | ||
| Q2 25 | — | 6.7% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | 23.3% | -7.0% | ||
| Q3 24 | 26.7% | -12.0% | ||
| Q2 24 | 29.4% | -11.5% | ||
| Q1 24 | 28.9% | -34.8% |
| Q4 25 | 16.5% | 4.4% | ||
| Q3 25 | 14.1% | 8.8% | ||
| Q2 25 | 18.0% | 7.2% | ||
| Q1 25 | 23.6% | 0.1% | ||
| Q4 24 | 17.7% | -13.5% | ||
| Q3 24 | 19.7% | -12.1% | ||
| Q2 24 | 21.8% | -13.0% | ||
| Q1 24 | 23.3% | -33.4% |
| Q4 25 | $0.55 | $0.05 | ||
| Q3 25 | $0.68 | $0.08 | ||
| Q2 25 | $0.78 | $0.06 | ||
| Q1 25 | $1.15 | $0.00 | ||
| Q4 24 | $0.73 | $-0.10 | ||
| Q3 24 | $0.81 | $-0.09 | ||
| Q2 24 | $0.90 | $-0.09 | ||
| Q1 24 | $1.02 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.1B | $4.5B |
| Total DebtLower is stronger | $7.6B | $836.4M |
| Stockholders' EquityBook value | $12.6B | $4.4B |
| Total Assets | $30.0B | $8.2B |
| Debt / EquityLower = less leverage | 0.61× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.1B | $4.5B | ||
| Q3 25 | $1.2B | $4.0B | ||
| Q2 25 | $8.9B | $2.8B | ||
| Q1 25 | $669.0M | $2.5B | ||
| Q4 24 | $685.0M | $2.6B | ||
| Q3 24 | $968.0M | $2.7B | ||
| Q2 24 | $1.1B | $2.6B | ||
| Q1 24 | $591.0M | $2.8B |
| Q4 25 | $7.6B | $836.4M | ||
| Q3 25 | $7.7B | — | ||
| Q2 25 | $7.5B | — | ||
| Q1 25 | $3.8B | — | ||
| Q4 24 | $3.8B | — | ||
| Q3 24 | $3.6B | — | ||
| Q2 24 | $4.1B | — | ||
| Q1 24 | $3.9B | — |
| Q4 25 | $12.6B | $4.4B | ||
| Q3 25 | $12.4B | $4.1B | ||
| Q2 25 | $11.6B | $3.8B | ||
| Q1 25 | $6.8B | $3.5B | ||
| Q4 24 | $6.4B | $3.3B | ||
| Q3 24 | $6.5B | $3.4B | ||
| Q2 24 | $6.0B | $3.4B | ||
| Q1 24 | $5.8B | $3.4B |
| Q4 25 | $30.0B | $8.2B | ||
| Q3 25 | $29.4B | $7.6B | ||
| Q2 25 | $25.6B | $6.3B | ||
| Q1 25 | $16.8B | $5.8B | ||
| Q4 24 | $17.6B | $5.9B | ||
| Q3 24 | $17.5B | $5.8B | ||
| Q2 24 | $15.9B | $5.7B | ||
| Q1 24 | $14.8B | $5.7B |
| Q4 25 | 0.61× | 0.19× | ||
| Q3 25 | 0.62× | — | ||
| Q2 25 | 0.65× | — | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 0.59× | — | ||
| Q3 24 | 0.55× | — | ||
| Q2 24 | 0.68× | — | ||
| Q1 24 | 0.67× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $444.0M | $417.3M |
| Free Cash FlowOCF − Capex | $424.0M | $379.8M |
| FCF MarginFCF / Revenue | 26.4% | 25.4% |
| Capex IntensityCapex / Revenue | 1.2% | 2.5% |
| Cash ConversionOCF / Net Profit | 1.68× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $1.4B | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $444.0M | $417.3M | ||
| Q3 25 | $468.0M | $402.6M | ||
| Q2 25 | $325.0M | $263.6M | ||
| Q1 25 | $213.0M | $44.1M | ||
| Q4 24 | $361.0M | $75.2M | ||
| Q3 24 | $440.0M | $188.4M | ||
| Q2 24 | $360.0M | $-95.6M | ||
| Q1 24 | $13.0M | $-308.6M |
| Q4 25 | $424.0M | $379.8M | ||
| Q3 25 | $452.0M | $354.5M | ||
| Q2 25 | $310.0M | $219.8M | ||
| Q1 25 | $196.0M | $-12.3M | ||
| Q4 24 | $341.0M | $-17.3M | ||
| Q3 24 | $417.0M | $54.7M | ||
| Q2 24 | $334.0M | $-205.5M | ||
| Q1 24 | $0 | $-465.1M |
| Q4 25 | 26.4% | 25.4% | ||
| Q3 25 | 28.1% | 25.1% | ||
| Q2 25 | 24.1% | 16.7% | ||
| Q1 25 | 14.0% | -1.1% | ||
| Q4 24 | 28.8% | -1.5% | ||
| Q3 24 | 35.2% | 5.5% | ||
| Q2 24 | 28.4% | -22.1% | ||
| Q1 24 | 0.0% | -61.9% |
| Q4 25 | 1.2% | 2.5% | ||
| Q3 25 | 1.0% | 3.4% | ||
| Q2 25 | 1.2% | 3.3% | ||
| Q1 25 | 1.2% | 5.0% | ||
| Q4 24 | 1.7% | 8.2% | ||
| Q3 24 | 1.9% | 13.3% | ||
| Q2 24 | 2.2% | 11.8% | ||
| Q1 24 | 1.0% | 20.8% |
| Q4 25 | 1.68× | 6.28× | ||
| Q3 25 | 2.06× | 3.22× | ||
| Q2 25 | 1.41× | 2.79× | ||
| Q1 25 | 0.64× | 34.71× | ||
| Q4 24 | 1.73× | — | ||
| Q3 24 | 1.88× | — | ||
| Q2 24 | 1.40× | — | ||
| Q1 24 | 0.04× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BRO
| US | $1.4B | 87% |
| GB | $147.0M | 9% |
| Profit Sharing Contingent Commission Revenue | $33.0M | 2% |
| Other Supplemental Commissions Revenue | $25.0M | 2% |
ONC
Segment breakdown not available.
